Ethnopharmacological Relevance: Danhong injection (DHI), a traditional Chinese medicine (TCM) injection that has been widely used to treat coronary heart disease and angina pectoris. However, its underlying pharmacological mechanisms have not been fully elucidated. Not all patients benefit from DHI to the same extent. We attempted to explore the characteristics of potential therapeutic targets in different responsive populations.

Aim Of The Study: This study aimed to reveal the potential molecular mechanisms of DHI in treating chronic stable angina and identify potential therapeutic targets for DHI.

Materials And Methods: Based on a previous phase IV clinical trial of DHI in treating chronic stable angina, drug response modules were identified through structural entropy and similarity. Drug response-related genes were screened out based on the correlations between drug response module/module-related genes and clinical features and were assessed using a random forest model. Further validation was conducted using a hypoxia/reoxygenation (H/R) model.

Results: Seven DHI-related response modules were identified. Eight drug response-related genes were screened out, and principal component analysis showed that DHI responders were distinguished from responders in the control group based on their expression values. The combination of the two most important genes, SHC4 and PIP5K1P1, discriminated between responders and nonresponders with an area under the receiver operating characteristic curve (AUC) of 0.714; however, no significant difference was found in the AUC between the combination and a single gene. Reverse transcription-polymerase chain reaction showed that middle-dose DHI treatment significantly decreased SHC4 mRNA expression compared with that in the H/R group (P = 0.026), a finding consistent with our previous analysis of differentially expressed genes.

Conclusions: DHI comprehensively exerted a therapeutic effect by acting on multiple response modules related to angina pectoris and drug response-related genes. Our findings indicate that the dimensionality reduction strategy based on the target network-drug response module-therapeutic targets can contribute to revealing the mechanism of action of TCM compounds and guiding precise clinical medication.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jep.2022.115125DOI Listing

Publication Analysis

Top Keywords

drug response-related
16
chronic stable
12
stable angina
12
response modules
12
response-related genes
12
pharmacological mechanisms
8
danhong injection
8
injection treat
8
angina pectoris
8
potential therapeutic
8

Similar Publications

Regulation and application of mA modification in tumor immunity.

Sci China Life Sci

December 2024

Division of Abdominal Tumor Multimodality Treatment, Cancer Center, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China.

Article Synopsis
  • The mA modification is an important RNA modification that affects RNA processes such as transcription, splicing, stability, and translation, and it plays a crucial role in interactions between tumor cells and immune cells.
  • Recent findings indicate that mA modification helps tumor cells evade the immune system and can influence the expression of genes involved in immune responses, which could impact treatment outcomes.
  • The review discusses the potential of targeting mA modification to enhance immune therapies for cancer and emphasizes the importance of mA regulatory factors in predicting the success of these treatments.
View Article and Find Full Text PDF
Article Synopsis
  • Researchers investigated how oxidative stress response-related genes (OSRGs) impact lung adenocarcinoma (LUAD) to create a genetic signature that could predict patient prognosis and suggest treatment options.
  • They developed a risk prediction model using clinical data and various assay methods to analyze the relationship between gene expression and factors like immune cell infiltration and chemotherapy sensitivity.
  • The study concluded that the identified gene signature could serve as a reliable biomarker for predicting patient outcomes and therapy responses in LUAD, with specific findings on the effects of DKK1 on cell behavior.
View Article and Find Full Text PDF

Introduction: Dementia is one of the leading causes of disability among older people aged 60 years and above, with majority eventually being diagnosed with Alzheimer's disease (AD). Pharmacological agents approved for dementia include acetylcholinesterase enzyme (AChE) inhibitors like rivastigmine, donepezil and galantamine and the N-methyl-D-aspartate (NMDA) receptor antagonist memantine, prescribed as monotherapy or in combination with each other, depending on the severity of disease. There is currently no available study demonstrating the clinical response to these drugs for AD in the Filipino population.

View Article and Find Full Text PDF

Adverse effects of diethyl phthalate and butyl benzyl phthalate on circadian rhythms and sleep patterns in zebrafish larvae.

Ecotoxicol Environ Saf

December 2024

Center for Predictive Model Research, Division of Advanced Predictive Research, Korea Institute of Toxicology, Daejeon, 34114, Korea; Human and Environmental Toxicology, University of Science and Technology, Daejeon 34113, South Korea. Electronic address:

The zebrafish, a diurnal vertebrate, is commonly used in circadian rhythm studies due to its genetic and neurological similarities to humans. Circadian rhythms, which regulate sleep, neurotransmitter, behavior, and physiological responses to environmental changes, can be disrupted by various environmental factors. Phthalic acid esters (PAEs) are pervasive endocrine disruptors that individuals are frequently exposed to in daily life.

View Article and Find Full Text PDF

Gemcitabine is a standard first-line drug for pancreatic cancer chemotherapy. Nevertheless, gemcitabine resistance is common and significantly limits its therapeutic efficacy, impeding advancements in pancreatic cancer treatment. In this study, through a comprehensive analysis of gemcitabine-resistant cell lines and patient samples, 39 gemcitabine resistance-associated risk genes were identified, and two distinct gemcitabine response-related phenotypes were delineated.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!